Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Rachna T. Shroff
University of Arizona - Department of Medicine
Tucson, AZ 85721
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
144
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Randomised Phase 3 Study of Ivosidenib in
IDH1
-Mutant Chemotherapy-Refractory Cholangiocarcinoma
Number of pages: 261
Posted: 08 Dec 2019
Ghassan K. Abou-Alfa
,
Teresa Macarulla
,
Milind M. Javle
,
Robin K. Kelley
,
Sam J. Lubner
,
Jorge Adeva
,
James M. Cleary
,
Daniel V. Catenacci
,
Mitesh J. Borad
,
John Bridgewater
,
William P. Harris
,
Adrian G. Murphy
,
Do-Youn Oh
,
Jonathan Whisenant
,
Maeve A. Lowery
,
Lipika Goyal
, Rachna T. Shroff,
Anthony B. El-Khoueiry
,
Bin Fan
,
Bin Wu
,
Christina X. Chamberlain
,
Liewen Jiang
,
Camelia Gliser
,
Shuchi S. Pandya
,
Juan W. Valle
and
Andrew Zhu
Memorial Sloan Kettering Cancer Center - Department of Medicine, Hospital Vall d’Hebron, University of Texas at Houston - MD Anderson Cancer Center, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of Wisconsin-Madison - Carbone Cancer Center, Hospital Universitario 12 de Octubre - Department of Medical Oncology, Harvard University - Dana-Farber Cancer Institute, University of Chicago - Pritzker School of Medicine, Mayo Clinic Hospital - Phoenix, University College London - UCL Cancer Institute, University of Washington - Department of Medicine, Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center, Seoul National University - Department of Internal Medicine, Utah Cancer Specialists, Trinity College (Dublin), Harvard University - Department of Medicine, University of Arizona - Department of Medicine, University of Southern California - Norris Comprehensive Cancer Center, Agios Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., The Christie NHS Foundation Trust - Department of Medical Oncology and Harvard University - Cancer Center
Downloads
144
(511,933)
View PDF
Download
Abstract:
Cholangiocarcinoma; IDH1 mutation; Ivosidenib; Phase 3 study
Feedback